Sepsis is the main cause of nonrelapse mortality, and there are no published data on applicability of supportive care protocols from high-income countries such as Sri Lanka. The aim of the study was ...

Composition of health care contact days and mortality prediction among trial participants. This is an ASCO Meeting Abstract from the 2025 ASCO Quality Care Symposium. This abstract does not include a ...

Leukopenia may be seen in sepsis as one of the systemic inflammatory response syndrome (SIRS) criteria, ie, white blood cell count below 4000, and may portend a poor prognosis. But severe leukopenia, ...

We recommend that a specific anatomic diagnosis of infection requiring emergent source control be identified or excluded as rapidly as possible in patients with sepsis or septic shock, and that any ...

X4 Pharmaceuticals (XFOR) is a good speculative biotech play to look into. The reason I state that is because it has already reported positive results from a phase 3 study using its drug mavorixafor ...

52 North Health Ltd. raised $6 million in financing to bring its oncology products to the market including the Neutrocheck, a point-of-care device and app which monitors cancer patients at home at ...